Skip to main content
NIH funding notice RFA-DA-19-033

Virtual Reality Tools to Enhance Evidence Based Treatment of Substance Use Disorders (R43/R44 - Clinical Trial Optional)

Closed on March 20, 2019.

Posted
January 11, 2019
Close date
March 20, 2019
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,264,600 in first-year total cost, median $632,300.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 GXM-A (12)]2

Most frequent institutions

  1. APPLIEDVR, INC.1
  2. SOBER GRID, INC.1
Competing awards under RFA-DA-19-033 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2019Virtual Reality as an Opioid Sparing Treatment for Chronic Pain1R44DA050231-01MADDOX, WILLIAM TODDAPPLIEDVR, INC., CA$1,039,600ZDA1
2019Integration of Virtual Reality Mindfulness Application Within a Mobile-Based Recovery Platform to Support Rehab and Post-Rehab Engagement1R44DA050222-01MANN, BEAUREEVES, NANEASOBER GRID, INC., OH$225,000ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.